Search
for
Sort by
Research 181–210 of 1000+
- Finasteride-Induced Neuropsychiatric Reactions Are Well Established
- Finasteride-induced recurrent aphthous ulceration–like lesions: a case report with dechallenge–rechallenge confirmation
- Black phosphorus nanosheets encapsulated microneedle for multifunctional therapy for androgenic alopecia
- Gas-propelled anti-hair follicle aging microneedle patch for the treatment of androgenetic alopecia
- Scalp Tourniquets for Chemotherapy-Induced Alopecia
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia
- Psychotropic Medication and Drug-Related Alopecia
- ALOPECIA AS A CONSEQUENCE OF TACROLIMUS THERAPY IN RENAL TRANSPLANTATION?
- Exploring rat corpus cavernosum alterations induced by finasteride treatment and withdrawal
- Baricitinib-Induced Trichilemmal Cyst Reactivation in a Woman With Alopecia Areata
- Simvastatin-induced myoglobinuric acute kidney injury following ciclosporin treatment for alopecia universalis
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Necrosulfonamide promotes hair growth and ameliorates DHT-induced hair growth inhibition
- Overcoming hurdles: Side effects with old drugs and achieving success with novel drug in alopecia areata
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- Skin Targeting of An Optimized Caffeine Nanostructured Lipid Carrier With Improved Efficiency Against Chemotherapy Induced Alopecia
- Formulation, optimization & in-vivo evaluation of smartlipid nanocarrier gel of berberine in testosterone-induced androgenetic alopecia
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- Sequential Immunotherapy with Tofacitinib and Low-Dose IL-2 Induces Sustained Remission in Alopecia Areata: A Proof-of-concept monocentric study
- SKIN TARGETING OF AN OPTIMIZED CAFFEINE NANOSTRUCTURED LIPID CARRIER WITH IMPROVED EFFICIENCY AGAINST CHEMOTHERAPY INDUCED ALOPECIA
- Discovery of 7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1<i>H</i>-imidazol-5-yl]-1,3-benzothiazole (TASP0382088): A Potent and Selective Transforming Growth Factor-β Type I Receptor Inhibitor as a Topical Drug for Alopecia
- Dissolving microneedle patch loading dutasteride microspheres for the long-acting treatment of androgenetic alopecia
- Finasteride-induced depression: new insights into possible pathomechanisms
- Impact of taxol on dermal papilla cells — A proteomics and bioinformatics analysis
- Concomitant Alopecia Areata and Profound Bone Marrow Suppression: An Unusual Manifestation of Azathioprine Toxicity
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Diffuse Hair Loss Induced by Sertraline Use
- Peroxisome proliferator-activated receptor-γ signalling protects hair follicle stem cells from chemotherapy-induced apoptosis and epithelial–mesenchymal transition